ezogabine has been researched along with Hearing Loss, Sensorineural in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, GD; Salvi, R; Sheppard, AM | 1 |
| Ebers, O; Feuer, A; Halaszovich, CR; Leitner, MG; Oliver, D; Schreiber, DN | 1 |
2 other study(ies) available for ezogabine and Hearing Loss, Sensorineural
| Article | Year |
|---|---|
Potassium ion channel openers, Maxipost and Retigabine, protect against peripheral salicylate ototoxicity in rats.
Topics: Acoustic Stimulation; Animals; Carbamates; Cochlea; Cochlear Microphonic Potentials; Cytoprotection; Disease Models, Animal; Hearing Loss, Sensorineural; Indoles; KCNQ Potassium Channels; Large-Conductance Calcium-Activated Potassium Channels; Male; Otoacoustic Emissions, Spontaneous; Phenylenediamines; Potassium Channels; Rats, Sprague-Dawley; Sodium Salicylate; Tinnitus | 2015 |
Restoration of ion channel function in deafness-causing KCNQ4 mutants by synthetic channel openers.
Topics: Animals; Carbamates; CHO Cells; Cricetinae; Cricetulus; Hair Cells, Auditory, Outer; Hearing Loss, Sensorineural; KCNQ Potassium Channels; Models, Molecular; Mutant Proteins; Organometallic Compounds; Patch-Clamp Techniques; Phenylenediamines; Pyridines; Rats; Rats, Wistar; Recombinant Fusion Proteins | 2012 |